SPC112

Ólaparíb, og sölt og lausnarsambönd þar af

  • Status:
    Veitt
  • Application date:
    10.3.2015
  • Application published:
    15.4.2015
  • Grant published:
    15.5.2017
  • Max expiry date:
    11.3.2029
  • Next due date:
    31.3.2027
  • Medicine name:
    Lynparza
  • Medicine for children:
    No

Timeline

Today
10.3.2015Application
15.4.2015Publication
15.5.2017Registration
11.3.2027Expires

Marketing license

  • IS authorization number:
    EU/1/14/959/001
  • Date:
    14.1.2015
  • Foreign authorization number:
    EU/1/14/959/001
  • Date:
    16.12.2014

Owner

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 12.2.2024

Expires: 11.3.2025

Payer: Árnason Faktor ehf.

Number: 2

Paid: 21.2.2025

Expires: 11.3.2026

Payer: Árnason Faktor ehf.

Number: 3

Paid: 12.3.2026

Expires: 11.3.2027

Payer: Árnason Faktor ehf.

Upload documents